Telmisartan vs. Clonidine hydrochloride: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Telmisartan and Clonidine hydrochloride. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 51,423 people who take Telmisartan and Clonidine hydrochloride, and is updated regularly.
What is Telmisartan?
Telmisartan has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 9,161 Telmisartan users. Check the latest studies of Telmisartan.
What is Clonidine hydrochloride?
Clonidine hydrochloride has active ingredients of clonidine hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 5,642 Clonidine hydrochloride users. Check the latest studies of Clonidine hydrochloride.
51,423 people who take Telmisartan and Clonidine hydrochloride are studied.
Drugs being compared in this study:
- Clonidine Hydrochloride (clonidine hydrochloride)
- Telmisartan (telmisartan)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Telmisartan:
- not at all: 1.47 %
- somewhat: 11.72 %
- moderate: 37.09 %
- high: 39.46 %
- very high: 10.26 %
Clonidine Hydrochloride:
- not at all: 4.43 %
- somewhat: 25.12 %
- moderate: 36.08 %
- high: 23.52 %
- very high: 10.84 %
Want to compare Telmisartan with Clonidine hydrochloride?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
Related studies
Alternative drugs to, pros and cons of:
- Telmisartan (8,644 reports)
- Clonidine hydrochloride (4,630 reports)
Browse all side effects of Telmisartan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Clonidine hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on telmisartan and clonidine hydrochloride (the active ingredients of Telmisartan and Clonidine hydrochloride, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Xanax and Alcohol Use for Women aged 30-39 - 5 seconds ago
- Xanax and Alcohol Detoxification for Women aged 30-39 - 5 seconds ago
- Xanax and Alcohol Problem for Women aged 30-39 - 6 seconds ago
- Xanax and Alcohol Rehabilitation for Women aged 30-39 - 6 seconds ago
- Xanax and Alcohol Dependence for Women aged 30-39 - 6 seconds ago
- Xanax and Alcohol Abuse for Women aged 30-39 - 6 seconds ago
- Xanax and Alcoholism for Women aged 30-39 - 7 seconds ago
- Benzonatate and Ckd for Women aged 50-59 - 16 seconds ago
- Benzonatate and Chronic Kidney Disease for Women aged 50-59 - 16 seconds ago
- Oxycodone Hydrochloride and Hydrocortisone drug interactions for women aged 50-59 - 18 seconds ago